Background Differences in the distribution of individual-level clinical risk factors across
regions do not fully explain the observed global disparities in COVID-19 outcomes. We …

Background Rheumatoid arthritis has been associated with severe COVID-19, but few
studies have investigated how phenotypes of rheumatoid arthritis affect these associations …

Background As the COVID-19 pandemic continues worldwide, severe COVID-19 outcomes
remain a major concern for patients with rheumatic and musculoskeletal diseases. We …

To provide recent statistics on worldwide gout epidemiology. Current and prediction data on
gout epidemiology were retrieved from the Global Health Data Exchange (GHDx) registry …

Background The impact and consequences of the COVID-19 pandemic on people with
rheumatic disease are unclear. We developed the COVID-19 Global Rheumatology Alliance …

Objectives To calculate the rates of COVID-19 infection and COVID-19-related death among
people with rare autoimmune rheumatic diseases (RAIRD) during the first wave of the …

Objective To determine whether patients with rheumatoid arthritis (RA) are at higher risks for
SARS–CoV‐2 infection and its severe outcomes before and after COVID‐19 vaccination …

Objectives To determine the severity and outcome of COVID-19 among individuals with
lupus as compared to controls. The secondary objective was to identify the risk association …

Background The highest number of COVID-19 cases in Italy have been reported in
Lombardy, a region in northern Italy. We aimed to analyse the course of severe acute …

Background Studies on long-term consequences of COVID-19, commonly referred to as post-
COVID condition, in patients with inflammatory rheumatic diseases are scarce and …